SB 1022

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for drug overdose medication.

In committee Last action October 3, 2025: Referred to Health & Human Services

Official bill page and text: palegis.us

Sponsors 8

Prime sponsor: Amanda Cappelletti
Cosponsors (7): Art Haywood, Christine Tartaglione, Jay Costa, John Kane, Judith Schwank, Nick Miller, Nikil Saval

Status

In committee as of October 3, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
October 3, 2025	Senate	Referred to Health & Human Services

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.